Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|October 27, 2019
The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)Francesca Caccuri, Antonella Bugatti, Silvia Corbellini, et al.
Blood|January 21, 2012
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activationCinzia Giagulli, Anna K Magiera, Antonella Bugatti, et al.
Journal of the American Chemical Society|August 7, 2012
Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activationDaniele Maiolo, Stefania Mitola, Daria Leali, et al.
Journal of Virology|October 20, 2006
Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virusJan Balzarini, Kristel Van Laethem, Dirk Daelemans, et al.
Ebiomedicine|June 25, 2017
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 InfectionSilvia Agostini, Hashim Ali, Chiara Vardabasso, et al.
Biosensors & Bioelectronics|October 16, 2015
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomesGiuseppe Di Noto, Antonella Bugatti, Andrea Zendrini, et al.
Plos One|August 5, 2016
Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In VivoEgle Avizienyte, Claire L Cole, Graham Rushton, et al.
Oncotarget|November 7, 2014
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer modelKatrien Van Raemdonck, Nele Berghmans, Vincent Vanheule, et al.
Cancer Gene Therapy|October 23, 2020
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivationCinzia Giagulli, Francesca Caccuri, Simone Zorzan, et al.
Pharmacological Research|November 22, 2025
A broad-spectrum anti-angiogenic tetrapeptide regresses diabetic retinopathy through β-arrestin-1 binding and prevention of Akt phosphorylationAlberto Zani, Antonella Bugatti, Eleonora Maceroni, et al.
Pageof 7